November 13, 2020 Cancer patients at increased risk of severe outcomes from COVID-19 Patients with cancer have a much higher risk of severe outcomes and death from COVID-19 than non-cancer patients. In an analysis of 15 research studies involving more than 3,000 patients around the world, researchers found that cancer patients who contracted COVID-19 had a 23 per cent risk of mortality compared to non-cancer patients with COVID […]
November 10, 2020 New Unit to advance cancer prevention research and strategies A new Unit focusing on cancer prevention research and strategies has launched at Imperial and The Institute of Cancer Research, London. The Cancer Epidemiology and Prevention Unit (CEPRU) is a joint initiative between Imperial College London and The Institute of Cancer Research. Its vision is to be a global leader in advancing research on the […]
April 15, 2020 Imperial welcomes world-leading health, research and education designation Imperial College Academic Health Science Centre has been redesignated an AHSC for a further five years. The prestigious designation from the National Institute of Health Research and NHS England/Improvement recognises Imperial College AHSC as a centre of excellence in health research, education and patient care. The Imperial College AHSC is a University-NHS partnership that aims to accelerate the translation of scientific breakthroughs into […]